LENZ Therapeutics
Price & Volume
Stats
See moreOpen | $13.02 |
Previous Close | $12.82 |
Day Range | $12.76-$13.22 |
52W Range | $11.48-$50.40 |
Market Cap | $372M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $17.5M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $17.5M |
Diluted EPS | -$2.06 |
News
See moreYahoo Finance • 3 months ago
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
Yahoo Finance • 5 months ago
Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors
Yahoo Finance • 6 months ago
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright
Yahoo Finance • 7 months ago
LENZ Therapeutics GAAP EPS of -$0.53 beats by $0.05
About
CEO | Mr. Evert B. Schimmelpennink |
Address | 201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
